Delivery Order SPE2DB22D1106-SPE2DB24FEZG5

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Budesonide-Formoterol 80-4.5 10.2 GM, a pharmaceutical product, with a ceiling value of $3,540.00 and an ultimate completion date of November 21, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2 gram medication, with a ceiling value of $1,206.49. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. This award is not associated with a set-aside designation....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of budesonide-formoterol 160-4.5 10.2GM medical products. The contract has a ceiling value of $10,546.67 and a completion date of December 30, 2024. It is a delivery order contract with a firm fixed price pricing type. There was no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,484.70 for the supply of budesonide-formoterol 160-4.5 10.2GM medication. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through November 2024. The contract type is firm fixed price. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,629.62, is a Delivery Order for Budesonide-Formoterol 80-4.5 10.2GM medication, with a completion date of January 28, 2025. The contract is a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with an ultimate completion date of January 9, 2025 and a ceiling value of $1,556.92. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a specific set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of budesonide-formoterol 160-4.5 10.2GM medical products. The contract has a fixed-price, delivery order structure with a ceiling value of $1,769.78 and a completion date of July 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM medication. The $1,833.46 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Budesonide-Formoterol 80-4.5 10.2GM medication. The contract has a firm fixed price structure and a not-to-exceed ceiling value of $2,118.68. The contract was awarded as a Delivery Order with an ultimate completion date of September 30, 2024. Amerisourcebergen, through its Corporate Office division, will supply this critical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,289.97 delivery order contract is for the delivery of budesonide-formoterol 160-4.5 10.2 gram medication. The contract has a firm fixed price pricing type and an ultimate completion date of July 25, 2024. It is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEZG5
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of budesonide-formoterol 160-4.5 10.2 GM, a prescription medication, with a ceiling value of $5,992.45 and a completion date of June 28, 2024. The contract is a delivery order and has a firm fixed-price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 10:13 AM